Format

Send to

Choose Destination
See comment in PubMed Commons below
Enferm Infecc Microbiol Clin. 2005 Jan;23(1):32-40.

[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection].

[Article in Spanish]

Author information

  • 1Servicio de Enfermedades Infecciosas, Hospital Clínic-Universitari de Barcelona-IDIBAPS, Universitat de Barcelona, Spain.

Abstract

The chronic infection by the hepatits C virus represents a serious sanitary problem affecting 1-3% of the world-wide population. It is transmitted by sexual route, vertical route and mainly after blood exposure by percutanea route. While HIV shares similar routes of transmission, the co-infection HCV-HIV is very frequent and the chronic hepatopathy and complications associated with its clinical course are an important cause of morbi-mortality in this population. The gold standard of the treatment for the HCV, has been the interferon and later the combination therapy of interferon plus ribavirine. Currently, the combination of ribavirine and a new pegilated formulation of the interferon has become the standard in the treatment reaching rates of sustained viral response around 40-80%.

PMID:
15701331
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center